Document is current
Any future updates will be listed below
-
Authors
Takenaka-Ninagawa, Nana
Kim, Jinsol
Zhao, Mingming
Sato, Masae
Jonouchi, Tatsuya
Goto, Megumi
Yoshioka, Clémence Kiho Bourgeois
Ikeda, Rukia
Harada, Aya
Sato, Takahiko
Ikeya, Makoto
Uezumi, Akiyoshi
Nakatani, Masashi
Noguchi, Satoru
Sakurai, Hidetoshi
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science London (18K15119)
Japan Agency for Medical Research and Development (20bm0404044h0002, 20bm0104001h0008)
- License Information
-
More Information
Article History
Received: 6 May 2021
Accepted: 13 July 2021
First Online: 9 August 2021
Declarations
:
: This study was performed in accordance with the guidelines of the Declaration of Helsinki and conducted after obtaining written informed consent. The patient-derived iPSC generation protocols were approved by the Kyoto University Graduate School and Faculty of Medicine, Ethics Committee (approval numbers #R0091 and #G259). Experiments using human primary skeletal muscle cells were approved by both the Ethical Review Board for Clinical Studies at Fujita Health University and the Kyoto University Graduate School and Faculty of Medicine, Ethics Committee (approval number #Rin55). The written informed consents were obtained from the donors of the iPSCs and pMSCs used in this study. All animal experiments were carried out according to protocols approved by the Animal Research Committee of Kyoto University.
: Not applicable
: The authors declare that they have no competing interests.
